Indefinite Delivery Contract VA69D17D0150

The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various...

This is a single award Indefinite Delivery Contract issued by the Department of the Army Medical Command to Complete Pharmacy And Medical Solutions, LLC, a for-profit limited liability company. The contract is for the supply of compounded pharmaceutical products, with a period of performance ending on September 30, 2022 and a potential total value of $1,342,433.30. The specific task order provided is for the supply of ROPIVACAINE PF 0.2% 100 ML CADD, with a period of performance ending on...

The National Institutes of Health (NIH) Clinical Center has awarded a single-award, indefinite delivery contract to Quva Pharma, Inc. to provide non-patient-specific sterile compounded pharmaceutical products for patients at the NIH Clinical Center on an as-needed basis. The contract has a ceiling value of $250,000 and a period of performance ending on September 30, 2025. Quva Pharma, a specialized pharmaceutical company that operates as a 503B outsourcing facility, will supply sterile...

The National Acquisition Center, a civilian federal agency, has awarded a single-award Blanket Purchase Agreement (BPA) to Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals, for the procurement of the controlled substance sodium oxybate. The contract has a ceiling value of $38,500,000 and a period of performance through February 6, 2026. Hikma Pharmaceuticals USA Inc. is a foreign-owned, for-profit pharmaceutical manufacturer registered in the System for Award...

The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center has awarded a $6 million, single-award Indefinite Delivery Contract (IDC) to Central Admixture Pharmacy Services Inc. (Caps) for the provision of 503A compounded sterile preparations and parenteral nutrition solutions. Caps is a for-profit organization that operates as both a 503A traditional pharmacy and a 503B outsourcing facility, specializing in customized intravenous mixtures, sterile admixtures,...

The government has awarded a Blanket Purchase Agreement (BPA) to Nephron Sterile Compounding Center LLC, a woman-owned limited liability company, to provide pharmaceutical products and supplies to the Defense Health Agency (DHA). The BPA has a ceiling value of $4,000,000 and a period of performance through March 31, 2025. Under this BPA, Nephron has received two specific task orders to date. The first is a $20,625 firm fixed price award for various injectable pharmaceutical products including...

Central Admixture Pharmacy Services, Inc. (CAPS), a provider of compounded sterile preparations and pharmacy services, has been awarded a $6.5 million Blanket Purchase Agreement (BPA) by the Defense Health Agency (DHA). Under this IDV, CAPS will deliver a variety of compounded admixture medicines, total parenteral nutrition, and other sterile pharmaceutical products to support DHA medical programs. The contract has a period of performance through July 14, 2026, with no set-aside designation....

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Mayne Pharma Commercial LLC, doing business as Metrics Inc. The BPA is for the procurement of halobetasol and tazaroten pharmaceuticals under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The single-award BPA has a ceiling value of $5,216,518.00 and a period of performance through May 28, 2025. As a foreign-owned, for-profit manufacturer of goods, Mayne...

The subject federal contract IDV award is a $4,999,999.00 single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded on April 29, 2015 by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Wells Pharma of Houston LLC, a for-profit limited liability company, to provide 503B compounding pharmaceuticals. The IDC has a ceiling value of $441,181 and a performance period through September 2025, with no set-aside designation. As part of this IDC, the VA has issued two delivery orders to Wells Pharma: a $220,590.50 order in February 2024 and a $97,340.50...